(Health-NewsWire.Net, April 13, 2018 ) According to Publisher, the Global 3D Cell Culture Market is accounted for $458.26 million in 2016 and is expected to reach $1,856.44 million by 2023 growing at a CAGR of 22.1% during the forecast period. Increasing investment and R&D funding for cell based research, technological advancements, advantages of 3D culture techniques over 2D techniques, development of automated large-scale cell culture systems and increasing demand for organ transplantation & tissue engineering are some of the factors boosting the market growth. However, high cost of research, and dearth of infrastructure for research in developing countries are anticipated to hamper the market growth. Hence it is an opportunity for players to increase in R&D spending in the growing market to gain the traction.
Get Sample Copy @ http://www.reportsweb.com/inquiry&RW00011415511/sample
A 3D cell culture is an artificially created environment in which biological cells are permitted to grow or interact with their surroundings in all three dimensions. These 3D cultures are usually grown in bioreactors, small capsules in which the cells can grow into spheroids, or 3D cell colonies. Hospitals, pharmaceutical companies, research institutes and laboratories are adopting 3D cell culture for better outputs and the adoption rate is posed to increase rapidly during the forecast period.
By product, scaffold-based segment dominated the global market with largest share owing to variety of material and structural choices for scaffold. In 2016, cancer and stem cell research segment is expected to grow with a high CAGR during the forecast period owing to rising prevalence rate of cancer and augmented investments in R&D activities by both government and private sectors. North America accounted for largest share in the global market followed by Europe owing to rising government support, increasing incidence of cancer and introduction of new products in the market. However, Asia pacific is expected to witness the fastest growth over the forecast period.
Some of the key players profiled in the report include 3D Biomatrix, Inc., 3D Biotek LLC, Becton, Dickinson and Company, Corning Incorporated, Global Cell Solutions, Inc., InSphero AG, Lonza Group, Merck & Co., Inc., Nano 3D Biosciences Inc, Nanofiber Solutions Incorporation, PromoCell GmbH, Reinnervate Ltd (A subsidiary of ReproCELL) , Sigma Aldrich Corporation, Tecan Trading AG, Thermo Fisher Scientific and VWR International LLC. Products Covered: -Magnetic levitation & 3D Bioprinting -Microfluidics-based 3D Cell Culture -Scaffold-free Cell Culture -Scaffold-based 3D Cell Culture
Applications Covered: -Cancer and Stem Cell Research -Drug Discovery -Regenerative Medicine & Tissue Engineering -Cell Based Assays/Toxicity Screening -In Vivo Applications for Stem Cells -3D Printing/Microfluidics -Other Applications
For more information @ http://www.reportsweb.com/3d-cell-culture-global-market-outlook-2017-2023 End Users Covered: -Research laboratories and institutes -Hospitals and diagnostic centers -Biotechnology and pharmaceutical industries -Other End Users
Regions Covered: -North America -US -Canada -Mexico -Europe -Germany -UK -Italy -France -Spain -Rest of Europe -Asia Pacific -Japan -China -India -Australia -New Zealand -South Korea -Rest of Asia Pacific -South America -Argentina -Brazil -Chile -Rest of South America -Middle East & Africa -Saudi Arabia -UAE -Qatar -South Africa -Rest of Middle East & Africa
Make an enquiry: http://www.reportsweb.com/inquiry&RW00011415511/buying
ReportsWeb.com
Rajat Sahni
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com
|